查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608150

静脉液市场：按类型、成分、最终用户划分 - 全球预测 2025-2030

Intravenous Solutions Market by Type (Peripheral Parenteral Nutrition, Total Parenteral Nutrition), Composition Solution (Carbohydrates, Dextran, Heparin & Trace Element), End-users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年静脉输液市场规模为137.6亿美元，预计2024年将达到149.9亿美元，复合年增长率为9.13%，2030年将达253.8亿美元。

静脉输液是医疗保健的重要组成部分，是将必需的营养物质、药物和水合作用直接输送到血液中的一种手段。这种方法确保物质的快速吸收和运输，促进即时的治疗效果。在急诊医学、外科手术、慢性病管理和水化治疗等重症加护应用中，静脉输液的需求尤其明显。在医疗保健生态系统中，最终用途包括医院、门诊手术中心和居家照护，每种用途都需要可靠的静脉注射机制。主要成长动力包括世界人口老化、慢性和急性疾病盛行率上升以及家庭医疗保健的普及。电解质输液和维生素强化输液的市场开拓等技术进步将进一步推动市场扩张。治疗机会在于扩大门诊医疗服务和个人化治疗解决方案，并根据患者的独特需求提供精确剂量。然而，感染风险、严格的法规结构和原材料价格波动等挑战是主要阻碍因素。此外，对无菌运输和储存基础设施的需求增加了营运成本，限制了小型製造商的进入。创新领域包括监测患者生命征象、开发具有感测器的智慧输液系统以确保准确的流量，以及环保包装以减少对环境的影响。市场相关人员应考虑投资技术集成，例如用于远端监控静脉注射治疗的物联网设备，这可以优化治疗效果并提高患者的依从性。为了克服现有障碍并引领市场创新，继续专注于研究和开发，特别是具有成本效益和永续的解决方案非常重要。在临床需求和新兴医疗保健趋势的推动下，输液解决方案市场仍然充满活力。

主要市场统计
基准年[2023] 137.6亿美元
预测年份 [2024] 149.9亿美元
预测年份 [2030] 253.8亿美元
复合年增长率（%） 9.13%

市场动态：快速发展的静脉液市场的关键市场洞察

供需的动态交互作用正在改变静脉输液市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 胃肠道疾病、癌症和神经系统疾病等慢性和急性疾病的发生率增加
    • 增加静脉注射的监管核准
    • 增加製造商之间的策略联盟以加强产品系列
  • 市场限制因素
    • 维持输液费用高
  • 市场机会
    • 新兴经济体对静脉输液的需求不断增加
    • 产品改进和新创新可提高患者便利性
    • 静脉输注维生素C在结直肠癌患者的实施
  • 市场挑战
    • 静脉注射的副作用

波特五力：驾驭静脉液体市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解静脉输液市场的外部影响

外部宏观环境因素在塑造静脉液体市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解静脉输液市场的竞争状况

静脉液体市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵输液液市场供应商绩效评估

FPNV 定位矩阵是评估静脉输液市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製静脉液体市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，静脉液体市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 胃肠道疾病、癌症和神经系统疾病等慢性和急性疾病的发生率增加
      • 增加静脉输液的监管核准
      • 增加製造商之间的策略联盟以加强产品系列
    • 抑制因素
      • 流体维护成本高
    • 机会
      • 新兴经济体对静脉输液的需求增加
      • 为患者提供便利的产品改进和新创新
      • 维生素C滴注在结直肠癌患者的实施
    • 任务
      • 静脉输液的副作用
  • 市场区隔分析
    • 类型：不断增长的营养和代谢需求扩大了全静脉营养的使用
    • 最终使用者：医院和诊所的需求不断增加，以满足广大病患的需求
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 静脉液市场：依类型

  • 周边静脉营养
  • 全静脉营养

第七章 静脉液体市场构成方案

  • 碳水化合物
  • 聚葡萄糖
  • 肝素和微量元素
  • 肠外脂肪乳剂
  • 单剂量氨基酸溶液
  • 维生素和矿物质

第八章静脉液体市场：依最终使用者分类

  • 门诊手术中心
  • 医院/诊所
  • 长期照护设施
  • 专科诊所

第九章 北美、南美静脉输液市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太静脉液体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲静脉输液市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Hikma 宣布在美国发布 COMBOGESIC IV
    • Sanjivani Palantral Limited 与 HAL 合作生产静脉注射製剂和静脉注射套件
    • CTMUHB 和 Baxter 合作实现更安全的静脉输液
  • 战略分析和建议

公司名单

  • Ajinomoto Co., Inc.
  • Amanta Healthcare Ltd.
  • Anhui Medipharm Co. Ltd
  • Axa Parenterals Ltd
  • B. Braun Melsungen AG
  • Baxter International Inc
  • Becton, Dickinson and Company
  • Enzymes Pharmaceuticals
  • Eurolife Healthcare Pvt. Ltd.
  • Fresenius SE & Co. KGaA
  • Grifols, SA
  • ICU Medical, Inc.
  • JW Life Science Corporation
  • Lxir Medilabs Pvt. Ltd.
  • Nymak Pharma Ltd.
  • Otsuka Holdings Co., Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited
  • Schwitz Biotech
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • Soxa Formulations & Research Pvt. Ltd.
  • Terumo Corporation
  • Trumac Healthcare
  • Varni Corporation
  • Vifor Pharma Management Ltd.
Product Code: MRR-710B1F0AC675

The Intravenous Solutions Market was valued at USD 13.76 billion in 2023, expected to reach USD 14.99 billion in 2024, and is projected to grow at a CAGR of 9.13%, to USD 25.38 billion by 2030.

Intravenous (IV) solutions are a critical component in medical care, serving as a means for delivering essential nutrients, medications, and hydration directly into the bloodstream. This method ensures rapid absorption and transport of substances, facilitating immediate therapeutic effects. The necessity of IV solutions is particularly prominent in emergency medicine, surgeries, chronic illness management, and hydration therapy, among other critical care applications. Within the healthcare ecosystem, the end-use scope extends to hospitals, ambulatory surgical centers, and home care settings, each requiring reliable IV delivery mechanisms. Key growth drivers include an aging global population, rising prevalence of chronic and acute illnesses, and the increasing adoption of home healthcare. Technological advancements, such as the development of electrolyte-infused and vitamin-enriched solutions, further enhance market expansion. Opportunities lie in expanding outpatient care services and individualized treatment solutions with accurate dosing according to patients' specific needs. However, challenges such as the risk of infections, stringent regulatory frameworks, and fluctuating raw material prices pose significant restraints. Additionally, the necessity for sterile transport and storage infrastructure elevates operational costs, limiting entry for small-scale manufacturers. Areas ripe for innovation include the development of smart infusion systems equipped with sensors for monitoring patient vitals and ensuring accurate flow rates, as well as eco-friendly packaging to reduce environmental impact. Market players should consider investing in technological integrations such as Internet of Things (IoT) devices for remote monitoring of intravenous therapies, which can optimize treatment efficacy and enhance patient compliance. Maintaining focus on research and development, particularly around cost-effective and sustainable solutions, will be crucial in overcoming existing barriers and leading market innovations. The market for IV solutions remains dynamic, driven by both clinical needs and emerging healthcare trends.

KEY MARKET STATISTICS
Base Year [2023] USD 13.76 billion
Estimated Year [2024] USD 14.99 billion
Forecast Year [2030] USD 25.38 billion
CAGR (%) 9.13%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Intravenous Solutions Market

The Intravenous Solutions Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
    • Increasing Regulatory Approvals for Intravenous Solution Injections
    • Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
  • Market Restraints
    • High Cost of Maintenance of Fluids
  • Market Opportunities
    • Increase in Demand for Intravenous Solutions from Developing Economies
    • Improvements and New Innovations in the Products for Patient Convenience
    • Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
  • Market Challenges
    • Side Effects of Intravenous Fluids

Porter's Five Forces: A Strategic Tool for Navigating the Intravenous Solutions Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Intravenous Solutions Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Intravenous Solutions Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Intravenous Solutions Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Intravenous Solutions Market

A detailed market share analysis in the Intravenous Solutions Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Intravenous Solutions Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Intravenous Solutions Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Intravenous Solutions Market

A strategic analysis of the Intravenous Solutions Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Intravenous Solutions Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Amanta Healthcare Ltd., Anhui Medipharm Co. Ltd, Axa Parenterals Ltd, B. Braun Melsungen AG, Baxter International Inc, Becton, Dickinson and Company, Enzymes Pharmaceuticals, Eurolife Healthcare Pvt. Ltd., Fresenius SE & Co. KGaA, Grifols, S.A., ICU Medical, Inc., JW Life Science Corporation, Lxir Medilabs Pvt. Ltd., Nymak Pharma Ltd., Otsuka Holdings Co., Ltd., Pfizer Inc., Salius Pharma Private Limited, Schwitz Biotech, Sichuan Kelun Pharmaceutical Co., Ltd., Soxa Formulations & Research Pvt. Ltd., Terumo Corporation, Trumac Healthcare, Varni Corporation, and Vifor Pharma Management Ltd..

Market Segmentation & Coverage

This research report categorizes the Intravenous Solutions Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Peripheral Parenteral Nutrition and Total Parenteral Nutrition.
  • Based on Composition Solution, market is studied across Carbohydrates, Dextran, Heparin & Trace Element, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, and Vitamins & Minerals.
  • Based on End-users, market is studied across Ambulatory Surgical Centers, Hospitals & Clinics, Long-term Care Facilities, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the Incidence of Chronic and Acute Diseases such as Gastrointestinal Disorder, Cancer, and Neurological Diseases
      • 5.1.1.2. Increasing Regulatory Approvals for Intravenous Solution Injections
      • 5.1.1.3. Rise in Strategic Collaborations Between Manufacturers to Enhance their Product Portfolio
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Maintenance of Fluids
    • 5.1.3. Opportunities
      • 5.1.3.1. Increase in Demand for Intravenous Solutions from Developing Economies
      • 5.1.3.2. Improvements and New Innovations in the Products for Patient Convenience
      • 5.1.3.3. Implementation of Vitamin C Intravenous for Patients with Colorectal Cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects of Intravenous Fluids
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Widening use of total parenteral nutrition owing to rising nutritional and metabolic needs
    • 5.2.2. End-Users: Rising demand from hospitals & clinics to cater to a broad spectrum of patient needs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Intravenous Solutions Market, by Type

  • 6.1. Introduction
  • 6.2. Peripheral Parenteral Nutrition
  • 6.3. Total Parenteral Nutrition

7. Intravenous Solutions Market, by Composition Solution

  • 7.1. Introduction
  • 7.2. Carbohydrates
  • 7.3. Dextran
  • 7.4. Heparin & Trace Element
  • 7.5. Parenteral Lipid Emulsion
  • 7.6. Single Dose Amino Acid Solution
  • 7.7. Vitamins & Minerals

8. Intravenous Solutions Market, by End-users

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Long-term Care Facilities
  • 8.5. Specialty Clinics

9. Americas Intravenous Solutions Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intravenous Solutions Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intravenous Solutions Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Hikma announces US launch of COMBOGESIC IV
    • 12.3.2. Sanjivani Paranteral Limited and HAL collaborate to manufacture IV formulations and IV Sets
    • 12.3.3. CTMUHB and Baxter partner to implement safer IV fluid administration
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ajinomoto Co., Inc.
  • 2. Amanta Healthcare Ltd.
  • 3. Anhui Medipharm Co. Ltd
  • 4. Axa Parenterals Ltd
  • 5. B. Braun Melsungen AG
  • 6. Baxter International Inc
  • 7. Becton, Dickinson and Company
  • 8. Enzymes Pharmaceuticals
  • 9. Eurolife Healthcare Pvt. Ltd.
  • 10. Fresenius SE & Co. KGaA
  • 11. Grifols, S.A.
  • 12. ICU Medical, Inc.
  • 13. JW Life Science Corporation
  • 14. Lxir Medilabs Pvt. Ltd.
  • 15. Nymak Pharma Ltd.
  • 16. Otsuka Holdings Co., Ltd.
  • 17. Pfizer Inc.
  • 18. Salius Pharma Private Limited
  • 19. Schwitz Biotech
  • 20. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 21. Soxa Formulations & Research Pvt. Ltd.
  • 22. Terumo Corporation
  • 23. Trumac Healthcare
  • 24. Varni Corporation
  • 25. Vifor Pharma Management Ltd.

LIST OF FIGURES

  • FIGURE 1. INTRAVENOUS SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 2. INTRAVENOUS SOLUTIONS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTRAVENOUS SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INTRAVENOUS SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HEPARIN & TRACE ELEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY PARENTERAL LIPID EMULSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SINGLE DOSE AMINO ACID SOLUTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS SOLUTIONS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY COMPOSITION SOLUTION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM INTRAVENOUS SOLUTIONS MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 149. INTRAVENOUS SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. INTRAVENOUS SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2023